ESCRS - PO152 - Clinical Evaluation Of Non-Diffractive Extended Vision Presbyopia And Astigmatism Correcting Intraocular Lens In Patients With Cataract And Keratoconus

Clinical Evaluation Of Non-Diffractive Extended Vision Presbyopia And Astigmatism Correcting Intraocular Lens In Patients With Cataract And Keratoconus

Published 2022 - 40th Congress of the ESCRS

Reference: PO152 | Type: ESCRS 2022 - Posters | DOI: 10.82333/m1fc-ck88

Authors: Altan Atakan Ozcan* 1 , Burak Ulas 1

1CUKUROVA UNIVERSITY SCHOOL OF MEDICINE,ADANA,Türkiye

Purpose

To describe the results of phacoemulsification and implantation of a non-diffractive extended vision presbyopia and astigmatism correcting intraocular lens (Acrysof IQ Vivity Toric) in patients with cataract and keratoconus.

Setting

Cukurova University School of Medicine, Adana-Turkey

Methods

Five patients with bilateral cataract and bilateral keratoconus was subjected to phacoemulsification with implantation of a Acrysof IQ Vivity toric IOL in both eyes. Corneal tomography was performed preoperatively using Scheimpflug technique with Pentacam. Patient satisfaction, photic phenomena, best-corrected visual acuity (BCVA), astigmatism, aberrations, spherical equivalent, and complications were compared postoperatively.

Results

A significant reduction in manifest cylinder and spherical equivalent was found and BCVA increased with a patient satisfaction at all distances. Neither additional aberrations, nor vision-compromising postoperative complications occurred and decentration or off-axis align of toric IOL was not observed.

Conclusions

Correction of both astigmatism and cataract with phacoemulsification and implantation of a toric Vivity IOL can be an effective and safe choice for selected patients with cataract and keratoconus. However, predicting the refractive outcome in cataract surgery is difficult in patients with keratoconus, and the surgeon should be aware of biometric errors, aberrations and the possible consequences.